Real-world healthcare costs amongst non-small cell lung cancer (NSCLC) patients tested with a host immune classifier (HIC)

被引：0
|
作者：
Iams, Wade Thomas
Le, Kimberly
Princic, Nicole
Marlin, Taylor
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Biodesix Inc, Boulder, CO USA
[3] Merative, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21187
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world healthcare resource utilization amongst non-small cell lung cancer (NSCLC) patients tested with a host immune classifier (HIC)
    Iams, Wade Thomas
    Le, Kimberly
    Princic, Nicole
    Marlin, Taylor
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Real-world demographics, baseline characteristics, healthcare resource utilization and costs amongst non-small cell lung cancer (NSCLC) patients tested with a Host Immune Classifier (HIC)
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    Winer, Isabelle
    Marlin, Taylor
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Healthcare Costs Amongst Patients with Non-Small Cell lung cancer (NSCLC) Before and After Testing with a Host Immune Classifier (HIC)
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E14 - E14
  • [4] Evaluation of Lines of Therapy Amongst Patients with NSCLC Tested with a Host Immune Classifier (HIC) in a Real-World Setting
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E14 - E15
  • [5] Healthcare Utilization Amongst Patients with NSCLC Before and After Testing with a Host Immune Classifier (HIC) in a Real-World Setting
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E13 - E14
  • [6] REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Lin, H. M.
    Pan, X.
    Hou, P.
    Huang, H.
    Baumann, P.
    Jahanzeb, M.
    VALUE IN HEALTH, 2019, 22 : S115 - S115
  • [7] REAL-WORLD HEALTHCARE COSTS IN PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER IN ITALY
    Danesi, V
    Massa, I
    Altini, M.
    Balzi, W.
    Gentili, N.
    Foca, F.
    Manunta, S.
    Ejzykowicz, F.
    Delmonte, A.
    VALUE IN HEALTH, 2019, 22 : S451 - S451
  • [8] REAL-WORLD COSTS OF LABORATORY TESTS FOR NON-SMALL CELL LUNG CANCER
    van der Linden, N.
    Smit, E. F.
    Uyl-De Groot, C. A.
    VALUE IN HEALTH, 2014, 17 (07) : A622 - A623
  • [9] Real-world costs of laboratory tests for non-small cell lung cancer
    van der Linden, Naomi
    Smit, Egbert F.
    Uyl-de Groot, Carin A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (08) : E187 - E189
  • [10] Immune-Related Adverse Events with Durvalumab Consolidation in a Real-World Cohort of Patients with Non-Small Cell Lung Cancer (NSCLC)
    Montenegro, G. Bravo
    Serzan, M.
    Belouali, A.
    Sackstein, P.
    Chen, K.
    Rao, S.
    Veytsman, I.
    Madhavan, S.
    Liu, S.
    Kim, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S366 - S366
12345